IYÚ, DAVID, GLENN, JACKIE R, WHITE, ANN E, FOX, SUE C and HEPTINSTALL, STAN, 2011. Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y12 Antagonist. Arteriosclerosis, thrombosis, and vascular biology. 31(2), 416-422 IYÚ, DAVID, JÜTTNER, MADLEN, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW J, FOX, SUSAN C and HEPTINSTALL, STAN, 2011. PGE(1) and PGE(2) modify platelet function through different prostanoid receptors. Prostaglandins & other lipid mediators. 94(1-2), 9-16 IYÚ, D, GLENN, J R, WHITE, A E, FOX, S C, VAN GIEZEN, H, NYLANDER, S and HEPTINSTALL, S, 2011. Mode of action of P2Y12 antagonists as inhibitors of platelet function. Thrombosis and Haemostasis. 105(1), 96-106 IYÚ, DAVID, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW J, FOX, SUSAN C and HEPTINSTALL, STAN, 2010. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. Platelets. 21(5), 329-342 HEPTINSTALL, STAN, ESPINOSA, DAVID IYU, MANOLOPOULOS, PANAGIOTIS, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW, DOVLATOVA, NATALIA, FOX, SUE C, MAY, JANE A, HERMANN, DAVID, MAGNUSSON, OLAFUR and STEFAN, 2008. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8), 605-13
MAY, JANE A, FOX, SUE, GLENN, JACKIE, CRAXFORD, SIMON and HEPTINSTALL, STAN, 2008. Platelet function reduces significantly during the morning. Platelets. 19(7), 556-8
MANOLOPOULOS, P, GLENN, J R, FOX, S C, MAY, J A, DOVLATOVA, N L, TANG, S-W, THOMAS, N R, RALEVIC, V and HEPTINSTALL, S, 2008. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents. Platelets. 19(2), 134-45
GLENN, J R, WHITE, A E, JOHNSON, A J, FOX, S C, MYERS, B and HEPTINSTALL, S, 2008. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Platelets. 19(1), 59-69
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and AND MYERS, B., 2007. Leucocytes influence platelet aggregation more than you think Platelets. 18(1), 77-78 WHITE, A., GLENN, J., FOX, S., JOHNSON, A., MYERS, B. and AND HEPTINSTALL, S., 2007. Reduced platelet aggregation to ADP and ATP in patients with leucocytosis is due to enhanced rates of adenine nucleotide metabolism mediated by the NTPDase CD39 Platelets. 18(1), 100 HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R and JOHNSON, A.J. AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Thrombosis Research. 120(Supplement 2), S153-S154
HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R, JOHNSON, A.J and AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-356
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54 HEPTINSTALL, STAN, GLENN, JACQUELINE R, JOHNSON, ANDREW, MYERS, BETHAN, WHITE, ANN E and ZHAO, LIAN, 2006. Leukocytosis, vascular disease, and adenine nucleotide metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology. 26(2), e22-3 HEPTINSTALL, S., GLENN, J.R., JOHNSTON, A., WHITE, A. and MYERS, B., 2006. Leucocytes, leucocytosis and adenine nucleotide metabolism. Platelets. 17, 115
HEPTINSTALL, S., FOX, S.C., GLENN, J.R., JOHNSON, A., WHITE, A.E., DOLAN, G. and MYERS, B., 2006. Blood leucocytes are mobile modulators of adenine metabolism and play an important role in determining the effects of adenine nucleotides on platelet function. Purinergic Signalling. 2, 137
HEPTINSTALL, S., MANOLOPOULOS, M., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N., TANG, S-W., BAUER, N., HESSE, M., THOMAS, N.R. and RALEVIC, V., 2006. Acyl derivatives of coenzyme A inhibit ADP-induced platelet function via antagonism at P2Y1 and P2Y12 receptors. Purinergic Signalling. 2, 92-93
GLENN, JACQUELINE R, WHITE, ANN E, JOHNSON, ANDREW, FOX, SUSAN C, BEHAN, MILES W H, DOLAN, GERRY and HEPTINSTALL, STANLEY, 2005. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood. Platelets. 16(3-4), 159-70 HEPTINSTALL,S., TANG,S., MANOLOPOULOS,P., FOX,S., MAY,J., GLENN,J. and RALEVIC,V., 2005. Derivatives of coenzymes A inhibit platelet aggregation via efects at P2Y1 and P2Y12 receptors. In: 20th Congress of the International Society on Thrombosis & Haemostasis. OR334
GLENN, J.R., WHITE, A.E., JOHNSON, A., FOX, S. and BEHAN, M.W., 2005. Raised blood leukocyte counts markedly alter platelet aggregation extent induced by ADP and ATP via CD39. In: International Society of Thrombosis and Haemostasis, Sydney Aug 2005. PO942